We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
STRO icon
3001
Sutro Biopharma
STRO
$343M
$53K ﹤0.01%
+688
New +$66K
AKTS
3002
DELISTED
Akoustis Technologies Inc
AKTS
$53K ﹤0.01%
+6,440
New +$49.8K
HCCI
3003
DELISTED
Heritage-Crystal Clean, Inc.
HCCI
$53K ﹤0.01%
+3,047
New +$51.3K
STFC
3004
DELISTED
State Auto Financial Corp
STFC
$53K ﹤0.01%
+2,944
New +$63.2K
ACWX icon
3005
iShares MSCI ACWI ex US ETF
ACWX
$12B
$52K ﹤0.01%
1,200
+293
+32% +$12K
CABA icon
3006
Cabaletta Bio
CABA
$461M
$52K ﹤0.01%
4,722
+1,755
+59% +$13.4K
CIVB icon
3007
Civista Bancshares
CIVB
$595M
$52K ﹤0.01%
3,379
+2,699
+397% +$39.3K
CRAI icon
3008
CRA International
CRAI
$1.06B
$52K ﹤0.01%
+1,321
New +$50.2K
EGO icon
3009
Eldorado Gold
EGO
$10.4B
$52K ﹤0.01%
5,343
-33,749
-86% -$293K
GRBK icon
3010
Green Brick Partners
GRBK
$3.05B
$52K ﹤0.01%
+4,426
New +$42.4K
LBRT icon
3011
Liberty Energy
LBRT
$3.58B
$52K ﹤0.01%
+9,603
New +$45K
MCFT icon
3012
MasterCraft Boat Holdings
MCFT
$595M
$52K ﹤0.01%
+2,739
New +$34.5K
RBBN icon
3013
Ribbon Communications
RBBN
$365M
$52K ﹤0.01%
+13,260
New +$48.2K
SCOR icon
3014
Comscore
SCOR
$112M
$52K ﹤0.01%
832
+783
+1,598% +$46.9K
SGRY icon
3015
Surgery Partners
SGRY
$1.92B
$52K ﹤0.01%
+4,438
New +$48.6K
VYGR icon
3016
Voyager Therapeutics
VYGR
$198M
$52K ﹤0.01%
+4,151
New +$48.3K
ATXI
3017
DELISTED
Avenue Therapeutics, Inc. Common Stock
ATXI
$52K ﹤0.01%
+4
New +$45.1K
CBAY
3018
DELISTED
Cymabay Therapeutics
CBAY
$52K ﹤0.01%
14,855
+9,327
+169% +$26.9K
IDEX
3019
DELISTED
Ideanomics, Inc. Common Stock
IDEX
$52K ﹤0.01%
+208
New +$24.1K
AMRS
3020
DELISTED
Amyris Inc.
AMRS
$52K ﹤0.01%
+11,995
New +$39.9K
VRAY
3021
DELISTED
ViewRay, Inc.
VRAY
$52K ﹤0.01%
+23,197
New +$49.5K
BLCM
3022
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
$52K ﹤0.01%
7,030
-5,887
-46% -$40.1K
RVI
3023
DELISTED
Retail Value Inc. Common Shares
RVI
$52K ﹤0.01%
+45,593
New +$51.6K
CPLG
3024
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
$52K ﹤0.01%
12,435
+9,726
+359% +$38K
ANIP icon
3025
ANI Pharmaceuticals
ANIP
$1.7B
$51K ﹤0.01%
+1,601
New +$57.4K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.